These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 15726917)

  • 1. Effects of estradiol on myocardial global performance index in hypertensive postmenopausal women.
    Aldrighi JM; Alecrin IN; Caldas MA; Gebara OC; Ramires JA; Rosano GM
    Gynecol Endocrinol; 2004 Nov; 19(5):282-92. PubMed ID: 15726917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of a single dose of oral estrogen on left ventricular diastolic function in hypertensive postmenopausal women with diastolic dysfunction.
    Fak AS; Erenus M; Tezcan H; Caymaz O; Oktay S; Oktay A
    Fertil Steril; 2000 Jan; 73(1):66-71. PubMed ID: 10632414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute and chronic effects of oestradiol on left ventricular diastolic function in hypertensive postmenopausal women with left ventricular diastolic dysfunction.
    Alecrin IN; Aldrighi JM; Caldas MA; Gebara OC; Lopes NH; Ramires JA
    Heart; 2004 Jul; 90(7):777-81. PubMed ID: 15201248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term estradiol replacement in postmenopausal women selectively mutes somatostatin's dose-dependent inhibition of fasting growth hormone secretion.
    Bray MJ; Vick TM; Shah N; Anderson SM; Rice LW; Iranmanesh A; Evans WS; Veldhuis JD
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3143-9. PubMed ID: 11443179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of transdermal 17beta-estradiol on left ventricular anatomy and performance in hypertensive women.
    Modena MG; Muia N; Aveta P; Molinari R; Rossi R
    Hypertension; 1999 Nov; 34(5):1041-6. PubMed ID: 10567179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous 17 beta-estradiol replacement therapy in hypertensive postmenopausal women.
    Osório-Wender MC; Vitola D; Spritzer PM
    Braz J Med Biol Res; 1997 Sep; 30(9):1047-53. PubMed ID: 9458963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-blind randomized placebo-controlled study of transdermal estrogen replacement therapy on hypertensive postmenopausal women.
    Modena MG; Molinari R; Muia N; Castelli A; Pala F; Rossi R
    Am J Hypertens; 1999 Oct; 12(10 Pt 1):1000-8. PubMed ID: 10560786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A short study in the treatment of hot flashes with buccal administration of 17-beta estradiol.
    Gass MS; Rebar RW; Cuffie-Jackson C; Cedars MI; Lobo RA; Shoupe D; Judd HL; Buyalos RP; Clisham PR
    Maturitas; 2004 Oct; 49(2):140-7. PubMed ID: 15474758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral estradiol administration modulates continuous intravenous growth hormone (GH)-releasing peptide-2-driven GH secretion in postmenopausal women.
    Shah N; Evans WS; Bowers CY; Veldhuis JD
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2649-59. PubMed ID: 10946861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postmenopausal women without previous or current vasomotor symptoms do not flush after abruptly abandoning estrogen replacement therapy.
    Hammar M; Ekblad S; Lönnberg B; Berg G; Lindgren R; Wyon Y
    Maturitas; 1999 Jan; 31(2):117-22. PubMed ID: 10227004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of ultralow-dose transdermal estradiol on postmenopausal symptoms in women aged 60 to 80 years.
    Diem S; Grady D; Quan J; Vittinghoff E; Wallace R; Hanes V; Ensrud K
    Menopause; 2006; 13(1):130-8. PubMed ID: 16607109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of estrogen replacement therapy on plasma levels of nitric oxide in postmenopausal women.
    Cicinelli E; Ignarro LJ; Matteo MG; Galantino P; Schonauer LM; Falco N
    Am J Obstet Gynecol; 1999 Feb; 180(2 Pt 1):334-9. PubMed ID: 9988796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of hormone replacement therapy on myocardial performance in early postmenopausal women.
    Duzenli MA; Ozdemir K; Sokmen A; Gezginc K; Soylu A; Celik C; Altunkeser BB; Tokac M
    Climacteric; 2010 Apr; 13(2):157-70. PubMed ID: 19672733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous-combined oral estradiol/drospirenone has no detrimental effect on cognitive performance and improves estrogen deficiency symptoms in early postmenopausal women: a randomized placebo-controlled trial.
    Davison SL; Bell RJ; Robinson PJ; Jane F; Leech J; Maruff P; Egan GF; Davis SR
    Menopause; 2013 Oct; 20(10):1020-6. PubMed ID: 23591255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasomotor hot flashes and heart rate variability: a placebo-controlled trial of postmenopausal hormone therapy.
    Lantto H; Haapalahti P; Tuomikoski P; Viitasalo M; Väänänen H; Sovijärvi AR; Ylikorkala O; Mikkola TS
    Menopause; 2012 Jan; 19(1):82-8. PubMed ID: 21934534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The short-term effects of different regimens of hormone replacement therapy on left ventricular structure and performance in healthy postmenopausal women. A prospective, controlled echocardiographic study.
    Fenkci V; Yilmazer M; Alpaslan M; Onrat E; Fenkci S
    Gynecol Obstet Invest; 2003; 55(3):139-44. PubMed ID: 12865592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral administration of 17beta-estradiol over 3 months without progestin co-administration does not improve coronary flow reserve in post-menopausal women: a randomized placebo-controlled cross-over CMR study.
    Schwitter J; Kozerke S; Bremerich J; Baltes C; Attenhofer Jost C; Birkhäuser M; Boesiger P; Buser P
    J Cardiovasc Magn Reson; 2007; 9(4):665-72. PubMed ID: 17578722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of high-dose estrogen and high-dose estrogen plus methyltestosterone treatment on cognitive task performance in postmenopausal women.
    Wisniewski AB; Nguyen TT; Dobs AS
    Horm Res; 2002; 58(3):150-5. PubMed ID: 12218381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postmenopausal oral estrogen therapy and blood pressure in normotensive and hypertensive subjects: the Estrogen in the Prevention of Atherosclerosis Trial.
    Steiner AZ; Hodis HN; Lobo RA; Shoupe D; Xiang M; Mack WJ
    Menopause; 2005; 12(6):728-33. PubMed ID: 16278616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estradiol supplementation in postmenopausal women doubles rebound-like release of growth hormone (GH) triggered by sequential infusion and withdrawal of somatostatin: evidence that estrogen facilitates endogenous GH-releasing hormone drive.
    Veldhuis JD; Anderson SM; Patrie JT; Bowers CY
    J Clin Endocrinol Metab; 2004 Jan; 89(1):121-7. PubMed ID: 14715838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.